Inactive Instrument

Press Releases AXCA HEALPAR

Equities

AXLA

US05454B2043

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Axcella Announces Reverse Stock Split Effective September 19, 2023	23-09-14	BU
Axcella Health : Submission of Matters to a Vote of Security Holders - Form 8-K	23-09-11	PU
"2023's Stocks to Watch Under $1 Unveiled: VTAK, AXLA, NVOS, MRIN, KAVL	23-09-11	AQ
Penny Stocks Stocks Poised To Pop On News (EPAZ, AXLA, NVOS, IQST)	23-09-05	AQ
CapitalGainsReport: Top Corona Stocks Watchlist (AXLA, BIXT, TOMDF, NVAX, MRNA)	23-08-30	AQ
Axcella Granted Patent for Long COVID Fatigue Treatment	23-08-29	BU
Axcella Health : Shareholder Director Nominations - Form 8-K	23-08-04	PU
Axcella Reports Second Quarter Financial Results and Provides Business Update	23-08-03	BU
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-05-04	AQ
AXCELLA HEALTH INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-04	AQ
Axcella Reports First Quarter Financial Results and Provides Business Update	23-05-04	BU
Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023	23-04-17	BU
Axcella Health : Trial investigating potential treatment for fatigue relief in people with long COVID reports results	23-04-14	PU
AXCELLA HEALTH INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-07	AQ
AXCELLA HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-30	AQ
AXCELLA HEALTH INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-30	AQ
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update	23-03-30	BU
Axcella Health : 10K HTML Q4 22	23-03-29	PU
AXCELLA HEALTH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-17	AQ
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue	23-02-15	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AXCA HEALPAR

Equities

AXLA

US05454B2043

Press Releases

Filters